Skip to main content
FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits - Firstpost 17-Jun-2020
FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits - Firstpost
In a separate announcement, the FDA has warned doctors against prescribing the HCQ in combination with remdesivir, the other drug shown to help COVID-19 patients.
More...